source
- PTC Therapeutics, Lilly to buy up bits of Sangamo in bankruptcy auctionThe bankrupt gene editing biotech Sangamo is set to sell chunks of its business to PTC Therapeutics and Eli Lilly for up to $264 million following an auction procedure. Sangamo said ...Endpoints · 10m ago↗ source
- STAT+: Neurocrine Biosciences and the delicate balance of benefit and riskWhen it comes to rare disease treatments, patients often confront a difficult risk-benefit calculus. Such is the case with a therapy from Neurocrine Biosciences.STAT · 11m ago↗ source
- STAT+: Newsom promotes affordable insulin, but California’s generic label is off to a slow startGov. Gavin Newsom is focused on making health care affordable, but his CalRx insulin has been slow to reach patients.STAT